Jefferies on Cabaletta Bio (CABA): 'We came away from EULAR 2026 update increasingly positive on the wholistic resecel profile'
Tweet Send to a Friend
Jefferies analyst Roger Song reiterated a Buy rating and $14.00 price target on Cabaletta Bio (NASDAQ: CABA).The analyst comments "Bottom ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
